You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Human T-Cell Lymphotropic Virus 1

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Evaluation of Patients With HAM/TSP

Recruiting
  • HTLV-I Infection
  • Tropical Spastic Paraparesis
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    HTLV-I Infection Trial run by the National Institute of Neurological Disorders and Stroke (NINDS) (Raltegravir)

    Completed
    • HTLV-I Infection
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 18, 2022

    Human T-Lymphotropic Virus Type 1 Associated Myelopathy Trial in Belém (Inspiratory muscle trainning, Exercise)

    Recruiting
    • Human T-Lymphotropic Virus Type 1 Associated Myelopathy
    • Inspiratory muscle trainning
    • Exercise
    • Belém, Pará, Brazil
      Universidade do Estado do Pará
    Apr 30, 2021

    Survival of Adult T-cell Leukemia / Lymphoma and Patients

    Recruiting
    • Lymphoproliferation Induced by HTLV-1
    • +2 more
      • Paris, France
        Hôpital Necker Enfants Malades
      Sep 26, 2022

      Adult T-Cell Lymphoma/Leukemia, Sezary Syndrome, Mycosis Fungoides Trial run by the NCI (Recombinant human Interleukin-15

      Completed
      Has Results
      • Adult T-Cell Lymphoma/Leukemia
      • +2 more
      • Recombinant human Interleukin-15 (rhIL-15)
      • Mogamulizumab
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Dec 9, 2022

      Oropharyngeal Cancer, Human Papilloma Virus, Head Neck Cancer Trial (Fludarabine, Cyclophosphamide, NEXI-003 T cells)

      Not yet recruiting
      • Oropharyngeal Cancer
      • +10 more
      • (no location specified)
      Dec 14, 2022

      Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type, Classical Hodgkin Lymphoma Trial in Houston (CD30.CAR-EBVST cells)

      Recruiting
      • Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type
      • Classical Hodgkin Lymphoma
      • CD30.CAR-EBVST cells
      • Houston, Texas
      • +1 more
      Jul 20, 2022

      Head Neck Cancer, Cervical Cancer, Non-small Cell Carcinoma Trial in Scottsdale, Chapel Hill (TSC-204-A0201, TSC-204-C0702,

      Not yet recruiting
      • Head and Neck Cancer
      • +20 more
      • TSC-204-A0201
      • +4 more
      • Scottsdale, Arizona
      • +1 more
      Aug 3, 2023

      Soft Tissue Sarcoma, Bone Sarcoma Trial in Houston (Cyclophosphamide, attIL2-T cells)

      Not yet recruiting
      • Soft Tissue Sarcoma
      • Bone Sarcoma
      • Houston, Texas
        M D Anderson Cancer Center
      Nov 10, 2022

      Myelodysplastic Syndrome, Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Myeloid Leukemia Trial in

      Recruiting
      • Myelodysplastic Syndrome
      • +16 more
      • Computed Tomography
      • +6 more
      • Scottsdale, Arizona
      • +2 more
      Feb 3, 2022

      B-cell Acute Lymphoblastic Leukemia Trial in Nanchang (Human CD19 Targeted DASH CAR-T Cells Injection)

      Recruiting
      • B-cell Acute Lymphoblastic Leukemia
      • Human CD19 Targeted DASH CAR-T Cells Injection
      • Nanchang, Jiangxi, China
        The Second Affiliated Hospital of Nanchang University
      Dec 13, 2022

      Advanced Malignancies Trial in Beijing (1A46 Drug Substance)

      Not yet recruiting
      • Advanced Malignancies
      • 1A46 Drug Substance
      • Beijing, Beijing, China
        Beijing Cancer Hospital
      Aug 4, 2023

      Lymphoma, Non-Hodgkin Trial (JNJ-87801493, JNJ-80948543, JNJ-75348780)

      Not yet recruiting
      • Lymphoma, Non-Hodgkin
      • (no location specified)
      Nov 15, 2023

      Acute Myeloid Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Cord Blood Transplant Recipient Trial in Houston

      Recruiting
      • Acute Myeloid Leukemia
      • +4 more
      • Recombinant Interleukin-7
      • Houston, Texas
        M D Anderson Cancer Center
      Jan 26, 2023

      Folliculotropic Mycosis Fungoides, Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma, Recurrent Mycosis Fungoides Trial in United

      Recruiting
      • Folliculotropic Mycosis Fungoides
      • +7 more
      • Durvalumab
      • +2 more
      • Duarte, California
      • +3 more
      Jan 12, 2023

      Hodgkin Disease, Non-Hodgkin Lymphoma, Severe Chronic Active Epstein Barr Virus Trial in Houston (MABEL CTLs, Cyclophosphamide,

      Recruiting
      • Hodgkin Disease
      • +5 more
      • MABEL CTLs
      • +2 more
      • Houston, Texas
      • +1 more
      Jan 13, 2023

      Multiple Sclerosis, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in Palo Alto

      Not yet recruiting
      • Multiple Sclerosis
      • +2 more
      • KYV-101 anti-CD19 CAR-T cell therapy
      • Standard lymphodepletion regimen
      • Palo Alto, California
        Stanford Multiple Sclerosis Center
      Nov 13, 2023

      Lupus Nephritis, Lupus Nephritis - World Health Organization (WHO) Class III, Lupus Nephritis - WHO Class IV Trial in Denver,

      Recruiting
      • Lupus Nephritis
      • +2 more
      • KYV-101 anti-CD19 CAR-T cell therapy
      • Standard lymphodepletion regimen
      • Denver, Colorado
      • +1 more
      Jul 7, 2023

      CNS Lymphoma Trial in Nanchang (Human CD19-CD22 Targeted T Cells Injection)

      Recruiting
      • Central Nervous System Lymphoma
      • Human CD19-CD22 Targeted T Cells Injection
      • Nanchang, Jiangxi, China
        The Second Affiliated Hospital of Nanchang University
      Dec 13, 2022

      Colorectal Cancer Trial in Stockholm, Västerås (pTTL)

      Recruiting
      • Colorectal Cancer
      • Stockholm, Sweden
      • +1 more
      Jun 7, 2023

      Lymphoma, B-Cell, Lymphoma, T-Cell Trial in Nashville (STP938)

      Recruiting
      • Lymphoma, B-Cell
      • Lymphoma, T-Cell
      • Nashville, Tennessee
        Tennessee Oncology
      Aug 3, 2022

      Respiratory Syncytial Virus Infections, Influenza, Human Trial in London (RSV A Memphis 37, Influenza A/California/04/2009)

      Terminated
      • Respiratory Syncytial Virus Infections
      • Influenza, Human
      • RSV A Memphis 37
      • Influenza A/California/04/2009
      • London, United Kingdom
        National Heart and Lung Institute, Imperial College London
      Jun 23, 2022

      Extranodal NK/T Cell Lymphoma, Nasal Type Trial in Guangdong (IBI318(Recombinant human anti-PD1/PD-L1 bispecific antibody))

      Active, not recruiting
      • Extranodal NK/T Cell Lymphoma, Nasal Type
      • IBI318(Recombinant human anti-PD1/PD-L1 bispecific antibody)
      • Guangdong, China
        Sun Yat-sen University Cancer Center
      Oct 10, 2022

      Virus Diseases Trial in London (ConM SOSIP 50 ug and ConS UFO 50 ug, Mos3.1 100 ug, Mos3.2 100 ug)

      Active, not recruiting
      • Virus Diseases
      • ConM SOSIP 50 ug and ConS UFO 50 ug
      • +4 more
      • London, Please Select..., United Kingdom
        NIHR Imperial Clinical Research Facility
      Jul 25, 2022

      Recurrent Adult T-Cell Leukemia/Lymphoma, Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Refractory Adult T-Cell

      Recruiting
      • Recurrent Adult T-Cell Leukemia/Lymphoma
      • +3 more
      • Columbus, Ohio
        Ohio State University Comprehensive Cancer Center
      Nov 18, 2022